Fatsia polycarpa Hayata is an evergreen shrub endemic to Taiwan and used locally to treat several inflammatory disorders. The crude extract of F. polycarpa has been proven to exhibit an antiinflammatory effect in vitro and in vivo; however, which constituents of the extract confer the antiinflammatory function remains unclear. Fatsicarpain D (Fat D) and fatsicarpain F (Fat F) are oleanane-type triterpenoids and two of the feature constituents of the F. polycarpa extract. Ester substitution on C-3 has been proposed to enhance the activities of triterpenoids. Thus, this study compared and characterized the antiinflammatory activities of Fat D, Fat F, and the C-3-acetylated derivatives thereof. These compounds were toxic to RAW 264.7 cells, but not to FL83B cells. The compounds dose-dependently inhibited tumor necrosis factor- (TNF-)-induced expression of inducible nitric oxide synthase in FL83B cells, with the IC 50 values being Fat D 8.5 M, acetylated Fat D 10.4 M, acetylated Fat F 10.7 M, and Fat F 27.4 M, respectively. Thus, acetylation of C-3 improved the activity of Fat F. Moreover, the compounds suppressed TNF--induced expression of nuclear factor-B (NF-B) p65 subunit and protein tyrosine phosphatase-1B. Furthermore, they inhibited TNF--mediated activation of the inhibitor kappa B kinase (IKK), and that of the mitogen-activated protein kinases (MAPKs) extracellular-signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK), but promoted the activation of MAPK p38, which was found to be antiinflammatory in certain cell types. Thus, Fat D and Fat F exhibited obvious antiinflammatory activities in vitro and inhibited ERK, JNK, and the IKK/NF-B pathway.
Plants of the genus Fatsia (belonging to the Araliaceae family) are mainly found in the archipelagos of the western Pacific Rim and the Bonin Islands [1] . Three species are known in the genus of Fatsia, namely Fatsia polycarpa Hayata, Fatsia japonica, and Fatsia oligocarpela [1] . F. polycarpa Hayata is an evergreen shrub endemic to Taiwan, whereas F. japonica and F. oligocarpela originate from Japan [1, 2] . The tissues of F. japonica are rich in triterpeniod saponins and have been recommended for treating several inflammatory diseases such as ankylosing spondylitis, osteoarthritis, rheumatism, rheumatoid arthritis, and tendinitis [3] . The leaves and twigs of F. polycarpa have been reported to contain abundant oleanane-type triterpenoids; seven oleanane-type triterpenoids peculiar to F. polycarpa, named fatsicarpains A-G, and two known oleanane-type triterpenoids [3-hydroxyolean-11,13(18)-dien-28-oic acid and 3-hydroxyolean-11-en-28,13-olide (HOEO)] have been isolated and identified [2] . Moreover, the crude extract of F. polycarpa and one of its feature constituents, HOEO, have been confirmed to exert antiinflammatory effects in vitro and in mouse models [4] . Whether other feature compounds, such as fatsicarpains A-G, also exhibit antiinflammatory functions merits further research.
Through preliminary screening, fatsicarpain D (Fat D) and fatsicarpain F (Fat F) exhibited potential antiinflammatory activities (data not shown). The structures of Fat D and Fat F are highly similar (Figure 1a) . The difference between them is that Fat F contains a methoxyl group on C-11, and thus the double bond between C-11 and C-9 in Fat D is absent in Fat F. Exploring how this difference affects the activities of the molecules is likely to yield useful results. Therefore, this study characterized and compared the antiinflammatory effects of Fat D and Fat F. According to structure-activity relationship studies, ester substitution on the C-3 hydroxyl group may enhance the activities of triterpenoids [5] [6] [7] . Therefore, C-3 acetylated Fat D (Fat D-Ac) and C-3 acetylated Fat F (Fat F-Ac) were generated (Figure 1a) , and the effect of the acetylation on the antiinflammatory activities of the molecules was investigated.
Stimulation of RAW 264.7 macrophage line by lipopolysaccharide (LPS) is a commonly used cellular model for antiinflammatory studies [8] [9] [10] . However, Fat D and Fat F have been shown previously to significantly inhibit the growth of RAW 264.7 cells in concentrations of 20 and 40 M (survival rate 32.95 ± 3.66% and 17.03 ± 1.77%, respectively, for Fat D; 77.72 ± 2.90% and 57.04 ± 6.91%, respectively, for Fat F), but not at 10 M (survival rate 82.11 ± 3.94% for Fat D, and 98.20 ± 12.00% for Fat F, respectively) [4] . Herein 10, 20, or 40 M Fat D-Ac or Fat F-Ac also showed an obvious inhibitory effect on the growth of RAW 264.7 cells (Figure 1b) , and the survival rate of Fat D-Ac-or Fat FAc-treated cells was lower than that of Fat D-or Fat F-treated cells, respectively, with the same concentration of the compound. These results revealed that the four compounds were toxic to RAW 264.7 cells, and that acetylation increased the toxicity of Fat D and Fat F to the macrophage line.
Tumor necrosis factor- (TNF-) is one of the major cytokines that is involved in numerous inflammatory diseases and pathological processes such as rheumatoid arthritis, bone fractures, Crohn's disease, and ankylosing spondylitis [11] [12] [13] . Previously, we showed that TNF- can induce inflammatory reactions in FL83B cells, including the activation of the inhibitor kappa B kinase (IKK)/nuclear factor-B (NF-B) pathway, and the elevated expression of the downstream effectors of the pathway, such as inducible nitric oxide synthase (iNOS), the p65 subunit of NF-B, and protein tyrosine phosphatase-1B (PTP-1B) [14] . Thus, TNF--treated FL83B cells can be employed as an inflammatory cellular model [14] . Fat D and Fat F have been shown to be nontoxic to FL83B cells at 5-40 M [4] . Similarly, as shown in Figure 1c , Fat D-Ac and Fat F-Ac did not display obvious cytotoxicity against FL83B cells at 5-40 M. Therefore, the four compounds were not toxic to FL83B cells, and acetylation did not increase the toxicity of the compounds to this cell line. Hence, the antiinflammatory effects of the compounds were characterized using FL83B cells. The mechanism underlying the distinct cytotoxic effects of the compounds on RAW 264.7 cells and FL83B cells is unclear. RAW 264.7 is a tumor and macrophage line, whereas FL83B is a normal hepatic line. Whether the compounds specifically inhibit the growth of tumor lines or macrophage lines deserves to be explored. The results suggested that Fat D has a higher antiinflammatory effect than Fat F does. Consistently, Fat D was more toxic to RAW 264.7 cells than Fat F [4] . The methoxyl group on C11 of Fat F decreases the hydrophobicity of Fat F compared with Fat D; this may reduce the penetration of Fat F into the cell through the cell membrane, or suppress the interaction of the compound with its cellular target(s). Consistently, Figure 2 suggested that the acetylation of Fat F, which elevated the hydrophobicity of the compound, improved the efficacy of the compound, because Fat FAc showed an obviously lower IC 50 than Fat F did. Hence, hydrophobicity may play a role in determining the efficacy of the compounds.
However, the acetylation of Fat D did not promote the efficiency of the compound, and resulted in a minor decrease in the activity of the compound. It is likely that the hydrophobicity of Fat D is high enough for its efficient entry into the cell; increasing the hydrophobicity through acetylation does not significantly enhance this efficiency, but the acetyl group may add some steric hindrance in the interaction of the compound with its cellular target(s). Therefore, the efficacy of Fat D was essentially not improved by C-3 acetylation.
To further ascertain the antiinflammatory activity of the compounds, TNF--induced expression of p65 and PTP-1B was also examined. As shown in Figure 3 Figure 2 . Overall, these data suggested that the compounds inhibited the TNF--mediated activation of IKK. This is likely a crucial mechanism underlying the antiinflammatory effects of the compounds. The band intensity of phosphorylated IKK relative to Lane 1 was determined after normalization by the sum of total IKK- and IKK-; that of phosphorylated IB or total IB relative to Lane 1 was determined after normalization by actin.
Mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK)1/2, c-Jun N-terminal kinase (JNK), and p38, are also known to mediate cytokine-induced inflammatory responses [17, 18] . However, p38 has been shown to have different functions in different cell types. In several cell types or tissues, p38 is actually antiinflammatory [19] [20] [21] , which may explain why , and f, Lanes 7 and 8) for 2 h and 50 min, followed by the addition of TNF- for another 10 min. Experiments were performed in duplicate. The band intensity of phosphorylated ERK, phosphorylated JNK, or phosphorylated p38 relative to Lane 1 was determined after normalization by that of total ERK, JNK, or p38, respectively. selective p38 inhibitors have failed to treat some inflammatory diseases in clinical trials [22, 23] . Thus, the effects of the compounds on the activation of the MAPKs were examined. As shown in Figure 5 Figure 5e and 5f revealed that TNF- moderately elevated the phosphorylation of p38 (Lanes 3 and 4), whereas the phosphorylation of p38 was further enhanced when either one of the compounds was added (Lanes 5-8). These results suggested that the compounds inhibited the activation of ERK and JNK, yet promoted that of p38. The inhibition of ERK and JNK is consistent with the antiinflammatory effects of the compounds. Whether the activation of p38 plays an antiinflammatory function in FL83B cells, and whether it is correlated with the antiinflammatory effects of the compounds, require further investigation. Overall, the results suggested that the molecular mechanism underlying the antiinflammatory activity of the compounds involves the inhibition of the IKK/NF-қB pathway, and the inhibition or activation of MAPKs.
In conclusion, Fat D, Fat F, and their acetylated derivatives all exhibit substantial antiinflammatory activity in TNF--treated cells. They inhibit the TNF--induced activation of IKK, and the expression of the downstream effectors of the IKK/NF-қB pathway iNOS, p65, and PTP-1B. Furthermore, the compounds repress the TNF--induced activation of ERK and JNK but promote the activation of p38. The efficacy of Fat D is the highest among the compounds when evaluated by the inhibitory effect on iNOS induction. Acetylation improves the activity of Fat F, but not that of Fat D. Fat D and Fat F may play roles in the antiinflammatory function of F. polycarpa.
Experimental
Chemicals: TNF- was purchased from R&D Systems (Minneapolis, MN, USA). Specific antibodies against phosphorylated IKK-IKK-, total IKK-, total IKK-, phosphorylated IB-, total IB-, phosphorylated JNK, total JNK, phosphorylated ERK, total ERK, phosphorylated p38, total p38, and p65 were purchased from Cell Signaling Technology (Beverly, MA, USA); an antibody against iNOS was purchased from BD Biosciences (Franklin Lakes, CA, USA). An actin-specific antibody was purchased from Chemicon (Temecula, CA, USA). A PTP-1B-specific antibody was purchased from Abcam (Cambridge, UK); all secondary antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Fetal bovine serum was purchased from Invitrogen (San Diego, CA, USA); and LPS derived from E. coli 055:B5, cell culture media, NaF, sodium orthovanadate, sodium pyrophosphate, and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] were purchased from Sigma-Aldrich (St. Louis, MO, USA) at reagent grade or cell-culture grade. Fat D (4 mg) and Fat F (2 mg) were isolated and identified previously from the leaves and twigs of F. polycarpa (7.1 kg) [2, 4] . The plant was identified by one of the authors (Chang-Hung Chou), and a voucher specimen (FPL) was deposited in the Research Center for Biodiversity, China Medical University, Taiwan, as described previously [2] . The acetylation of Fat D and Fat F was performed through reaction of the compounds with acetic anhydride in pyridine, and the structures of the products were elucidated by NMR and HR-ESI-MS analyses, as described previously [7] . The compounds were dissolved in DMSO as stock solutions.
Cell culture: RAW 264.7 cells and FL83B cells were purchased from the Bioresource Collection and Research Center (Hsinchu, Taiwan) and cultured at 37 °C in a humidified incubator supplied with 5% CO 2 using the medium specified in the supplier's instructions.
Western blot analysis: FL83B cells were seeded on 35-or 60-mm plates until they reached 80% to 90% confluence, washed with phosphate-buffered saline (PBS, pH 7.4), and incubated in a serumfree medium containing the investigated compound in the specified concentration or an equal volume of DMSO for 3 h, followed by adding 20 ng/mL of TNF- for another 3 h. Alternatively, for Western blot analyses of phosphorylated IKK, IB, ERK, JNK, and p38, the cells were treated with the investigated compound for 3 h, and in the last 10 min, 20 ng/mL of TNF- was added. Subsequently, cells were washed twice with cold PBS, subjected to cell lysis in a buffer, and harvested and centrifuged as described previously [4, 14] . The supernatant was collected and the protein
